Bolt Biotherapeutics, Inc.
BOLT • NASDAQ • Stock Fundamentals
Bolt Biotherapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William Quinn, with a market cap of $9.9M.
Market Cap$9.9M
Employees100.0
CEOWilliam Quinn
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Bolt Biotherapeutics, Inc. FAQ
Common questions about Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. (BOLT) has a market capitalization of $9.9M and trades on NASDAQ.
Bolt Biotherapeutics, Inc. has approximately 100 employees.